UAE approves Sinopharm's protein-based vaccine

Middle East
28-12-2021 | 03:07
High views
Share
LBCI
Share
LBCI
Whatsapp
facebook
Twitter
Messenger
telegram
telegram
print
UAE approves Sinopharm's protein-based vaccine
Whatsapp
facebook
Twitter
Messenger
telegram
telegram
print
0min
UAE approves Sinopharm's protein-based vaccine
The United Arab Emirates has approved emergency use of Sinopharm's protein-based COVID-19 vaccine and it will be available to the public as a booster dose starting January 2022, the health ministry said.
 
The vaccine will be produced and distributed by a joint venture between the UAE's Group 42 and China National Biotec Group (CNBG), a unit of China National Pharmaceutical Group (Sinopharm), the ministry said in a statement on state media on Monday.
 
The approval came following a UAE-based study that included individuals who were previously vaccinated with two doses of Sinopharm CNBG's inactivated vaccine, the ministry added.
 
The UAE, a federation of seven emirates, on Monday reported 1,732 new coronavirus cases and one death. Authorities, who do not give a breakdown for each emirate, said around 91% of the population of some 10 million had been fully vaccinated.
 
 
REUTERS
 

Breaking Headlines

UAE

Approval

Sinopharm

Protein

Vaccine

COVID-19

Cases

Infections

Download now the LBCI mobile app
To see the latest news, the latest daily programs in Lebanon and the world
Google Play
App Store
We use
cookies
We use cookies to make
your experience on this
website better.
Accept
Learn More